BACKGROUND: While several studies have examined the treatment of adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL), studies of acute myeloid leukemia (AML) are rare. Using national data for Australia, we describe (i) the number and type of treatment centers caring for AYAs, (ii) induction/first-line treatments, and (iii) survival outcomes. PROCEDURE: National population-based study assessing treatment of 15- to 24-year-olds diagnosed with ALL or AML between 2007 and 2012. Treatment details were abstracted from hospital medical records. Treatment centers were classified as pediatric or adult (adult AYA-focused or other adult; and by AYA volume [high/low]). Cox proportional hazard regression analyses examined associa...
Approaches to the management of adolescents and young adults with acute leukaemia were investigated ...
BackgroundLittle is known about outcomes of acute myeloid leukemia (AML) in adolescents and young ad...
Survival rates of adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) are in...
BackgroundStudies have demonstrated superior outcomes for adolescent and young adult (AYA) patients ...
Background: The objective was to compare 5-year overall survival (OS) between adolescent and young a...
Background: Treating adolescents and young adults (AYA) patients with acute lymphoblastic leukemia (...
Adolescents and young adults (AYAs, 15-39 years) with acute lymphoblastic leukemia (ALL) represent a...
Background Retrospective studies have shown adolescents and young adults (AYA) with acute lymphoblas...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
Studies on adolescents and young adults with acute lymphoblastic leukemia suggest better results whe...
Background: It remains unclear whether pediatric protocols provide a better outcome to adolescent an...
BACKGROUND: Adolescents with acute lymphoblastic leukaemia (ALL) have languished in the shadow of su...
The objectives of this review were to discuss standard and investigational treatment strategies for ...
Abstract: The objectives of this review were to discuss standard and investigational treatment strat...
BACKGROUND: Retrospective studies have shown adolescents and young adults (AYA) with acute lymphobla...
Approaches to the management of adolescents and young adults with acute leukaemia were investigated ...
BackgroundLittle is known about outcomes of acute myeloid leukemia (AML) in adolescents and young ad...
Survival rates of adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) are in...
BackgroundStudies have demonstrated superior outcomes for adolescent and young adult (AYA) patients ...
Background: The objective was to compare 5-year overall survival (OS) between adolescent and young a...
Background: Treating adolescents and young adults (AYA) patients with acute lymphoblastic leukemia (...
Adolescents and young adults (AYAs, 15-39 years) with acute lymphoblastic leukemia (ALL) represent a...
Background Retrospective studies have shown adolescents and young adults (AYA) with acute lymphoblas...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
Studies on adolescents and young adults with acute lymphoblastic leukemia suggest better results whe...
Background: It remains unclear whether pediatric protocols provide a better outcome to adolescent an...
BACKGROUND: Adolescents with acute lymphoblastic leukaemia (ALL) have languished in the shadow of su...
The objectives of this review were to discuss standard and investigational treatment strategies for ...
Abstract: The objectives of this review were to discuss standard and investigational treatment strat...
BACKGROUND: Retrospective studies have shown adolescents and young adults (AYA) with acute lymphobla...
Approaches to the management of adolescents and young adults with acute leukaemia were investigated ...
BackgroundLittle is known about outcomes of acute myeloid leukemia (AML) in adolescents and young ad...
Survival rates of adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) are in...